Top

Supportive Care in Cancer

Published in:

01-05-2016 | Original Article

Chemotherapy-induced gut toxicity and pain: involvement of TLRs

Authors: Rachel J. Gibson, Janet K. Coller, Hannah R. Wardill, Mark R. Hutchinson, Scott Smid, Joanne M. Bowen

Published in: Supportive Care in Cancer | Issue 5/2016

Abstract

Purpose

Chemotherapy-induced gut toxicity is associated with significant pain, and pain influences gut function. Toll-like receptors (TLRs) that regulate gut homeostasis are activated by tissue damage and microbes, and their altered expression following chemotherapy may change cellular responses. This study examined the interaction between chemotherapy-induced gut toxicity and pain and related these to gut TLR and glial fibrillary acidic protein (GFAP) expression.

Methods

Female tumor bearing Dark Agouti rats received irinotecan (175 mg/kg, n = 34) or vehicle (n = 5) and were assessed over 120 h for gut toxicity (diarrhea, weight loss), pain (facial), and GFAP, TLR2, 4, 5, and 9 gut expression.

Results

Irinotecan caused diarrhea (72 % of animals grade ≥ 1), weight loss (11.1 ± 6.6 %, P < 0.0001), and pain (5 (0–5), P < 0.0001) all peaking at 72 h. Higher pain scores were observed in rats with diarrhea versus those without: median (range) of 2.0 (0–5) versus 0 (0–5), P = 0.01. Irinotecan also caused a decrease in TLR4 and 5, and an increase in GFAP expression in jejuna crypt at 96 and 120 h (all P < 0.05); with lower TLR4 expression associated with lower pain (P = 0.012).

Conclusions

The association between gut toxicity and pain suggests these toxicities are linked, possibly via TLR-mediated inflammatory pathways. Further, as TLR4 and 5 expression was absent during recovery in the jejuna and GFAP expression was increased in the jejuna, this implies expression of these may be critical in the healing phase following chemotherapy. Detailed studies of gut TLRs and GFAP are now warranted.

Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5(9 Suppl 4):3–11PubMed

Stringer AM, Al-Dasooqi N, Bowen JM, Tan TH, Radazum M, Logan RM, Mayo B, Keefe DMK, Gibson RJ (2013) Potential biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations; intestinal inflammation and circulating matrix metalloproteinases. Support Care Cancer 21:1843–1852CrossRefPubMed

Carlotto A, Hogsett VL, Mairorini EM, Razulis JG, Sonis ST (2013) The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics 31:753–766CrossRefPubMed

Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632–637CrossRefPubMedPubMedCentral

Wardill HR, Van Sebille YZA, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST (2015) Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity. Cancer Treat Rev 41:122–128CrossRefPubMed

Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104–112. doi:10.1038/ni1018 CrossRefPubMed

Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397. doi:10.1038/41131 CrossRefPubMed

Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973–983CrossRefPubMed

Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8:1327–1336. doi:10.1038/ncb1500 CrossRefPubMed

10.

Umesaki Y, Setoyama H (2000) Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2:1343–1351CrossRefPubMed

11.

Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10:131–144CrossRefPubMed

12.

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241CrossRefPubMed

13.

Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2008) Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7:1139–1145CrossRefPubMed

14.

Logan RM, Gibson RJ, Bowen JM, Stringer AM, Sonis ST, Keefe DM (2008) Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis. Cancer Chemother Pharmacol 62:33–41. doi:10.1007/s00280-007-0570-0 CrossRefPubMed

15.

Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG (2002) Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 47:2751–2757CrossRefPubMed

16.

Cata JP, Weng HR, Dougherty PM (2008) Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy. Brain Res 1230:91–98. doi:10.1016/j.brainres.2008.07.022 CrossRefPubMedPubMedCentral

17.

Cata JP, Weng HR, Dougherty PM (2008) The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 1229:100–110. doi:10.1016/j.brainres.2008.07.001 CrossRefPubMedPubMedCentral

18.

Boogerd W, ten Bokkel Huinink WW, Dalesio O, Hoppenbrouwers WJ, van der Sande JJ (1990) Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement. J Neurooncol 9:255–263CrossRefPubMed

19.

Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109:132–142. doi:10.1016/j.pain.2004.01.021 CrossRefPubMed

20.

Connelly E, Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1996) Paclitaxel delivered as a 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol Oncol 62:166–168. doi:10.1006/gyno.1996.0210 CrossRefPubMed

21.

Tanner KD, Levine JD, Topp KS (1998) Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol 395:481–492. doi:10.1002/(SICI)1096-9861(19980615)395:4<481::AID-CNE5>3.0.CO;2-Y CrossRefPubMed

22.

Weng HR, Cordella JV, Dougherty PM (2003) Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain 103:131–138CrossRefPubMed

23.

Watkins LR, Maier SF, Goehler LE (1995) Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63:289–302CrossRefPubMed

24.

Ruhl A, Nasser Y, Sharkey KA (2004) Enteric glia. Neurogastroenterol Motil 16(Suppl 1):44–49. doi:10.1111/j.1743-3150.2004.00474.x CrossRefPubMed

25.

Toumi F, Neunlist M, Cassagnau E, Parois S, Laboisse CL, Galmiche JP, Jarry A (2003) Human submucosal neurones regulate intestinal epithelial cell proliferation: evidence from a novel co-culture model. Neurogastroenterol Motil 15:239–242CrossRefPubMed

26.

Van Landeghem L, Chevalier J, Mahe MM, Wedel T, Urvil P, Derkinderen P, Savidge T, Neunlist M (2011) Enteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGF. Am J Physiol Gastrointest Liver Physiol 300:G976–G987. doi:10.1152/ajpgi.00427.2010 CrossRefPubMedPubMedCentral

27.

Watson AJ, Duckworth CA, Guan Y, Montrose MH (2009) Mechanisms of epithelial cell shedding in the mammalian intestine and maintenance of barrier function. Ann N Y Acad Sci 1165:135–142. doi:10.1111/j.1749-6632.2009.04027.x CrossRefPubMed

28.

Logan RM, Gibson RJ, Sonis ST, Keefe DM (2007) Nuclear factor-kappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43:395–401. doi:10.1016/j.oraloncology.2006.04.011 CrossRefPubMed

29.

Sonis ST (2002) The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med 13:380–389CrossRefPubMed

30.

Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, Glick S, Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, Matsumiya L, Sorge RE, Sotocinal SG, Tabaka JM, Wong D, van den Maagdenberg AM, Ferrari MD, Craig KD, Mogil JS (2010) Coding of facial expressions of pain in the laboratory mouse. Nat Methods 7:447–449. doi:10.1038/nmeth.1455 CrossRefPubMed

31.

Gibson RJ, Bowen JM, Inglis MR, Cummins AG, Keefe DM (2003) Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol 18:1095–1100CrossRefPubMed

32.

Wardill HR, Bowen JM, Sultani M, Stringer AM, Stansborough R, Shirren J, Gibson RJ (2014) Irinotecan disrupts tight junction proteins within the gut: implications for chemotherapy-induced gut toxicity. Cancer Biol Ther 15:1–9CrossRef

33.

Al-Dasooqi N, Gibson RJ, Bowen JM, Logan RM, Stringer AM, Keefe DM (2010) Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the Dark Agouti rat. Exp Biol Med (Maywood) 235:1244–1256. doi:10.1258/ebm.2010.010082 CrossRef

34.

Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21–32, discussion 35–6 PubMed

35.

Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2009) Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63:239–251. doi:10.1007/s00280-008-0732-8

36.

Neunlist M, Aubert P, Bonnaud S, Van Landeghem L, Coron E, Wedel T, Naveilhan P, Ruhl A, Lardeux B, Savidge T, Paris F, Galmiche JP (2007) Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway. Am J Physiol Gastrointest Liver Physiol 292:G231–G241. doi:10.1152/ajpgi.00276.2005 CrossRefPubMed

37.

Zaks-Zilberman M, Zaks TZ, Vogel SN (2001) Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 15:156–165. doi:10.1006/cyto.2001.0935 CrossRefPubMed

38.

DeLeo JA, Yezierski RP (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1–6CrossRefPubMed

39.

Watkins LR, Maier SF (2003) Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2:973–985CrossRefPubMed

40.

Ledeboer A, Liu T, Shumilla JA, Mahoney JH, Vijay S, Gross MI, Vargas JA, Sultzbaugh L, Claypool MD, Sanftner LM, Watkins LR, Johnson KW (2006) The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol 2:279–291. doi:10.1017/S1740925X0700035X CrossRefPubMed

41.

Park HJ, Stokes JA, Corr M, Yaksh TL (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73:25–34CrossRefPubMed

42.

Byrd-Leifer CA, Block EF, Takeda K, Akira S, Ding A (2001) The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 31:2448–2457. doi:10.1002/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N CrossRefPubMed

43.

Neumann J, Schaale K, Farhat K, Endermann T, Ulmer AJ, Ehlers S, Relling N (2010) Frizzled1 is a marker of inflammatory macrophages, and its ligant Wnt3a is involved in reprogramming mycobacterium tuberculosis-infected macrophages. FASEB J 24:4599–4612CrossRefPubMed

44.

Camac KS, Thompson FM, Cummins AG (2007) Activation of beta-catenin in the stem cell region of crypts during growth of the small intestine in infant rats. Dig Dis Sci 52:1242–1246. doi:10.1007/s10620-006-9200-7 CrossRefPubMed

Title: Chemotherapy-induced gut toxicity and pain: involvement of TLRs
Authors: Rachel J. Gibson
Janet K. Coller
Hannah R. Wardill
Mark R. Hutchinson
Scott Smid
Joanne M. Bowen
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 5/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-3020-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2016

Piloting prostate cancer patient-reported outcomesin clinical practice

Risk factors for anthracycline-associated cardiotoxicity

Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer

Outpatient management of intensively treated acute leukemia patients—the patients’ perspective

Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF

Cardiorespiratory fitness and physical activity in children with cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer